Yesenia Japa
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.2% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,962, more than ten times the $123 reported in 2023. Among family clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $32.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Botanix SB Inc$1K
- LEO Pharma Inc.$991
- Dermavant Sciences, Inc.$802
- Incyte Corporation$624
- UCB, Inc.$510
- AbbVie$470
- plus $2K from 13 others
What the payments were for
- Consulting fees$60010%
- Food & beverage$5,59690%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Botanix SB Inc | 13 | $1,002 |
| LEO Pharma Inc. | 27 | $991 |
| Dermavant Sciences, Inc. | 17 | $802 |
| Incyte Corporation | 12 | $624 |
| UCB, Inc. | 35 | $510 |
| AbbVie | 21 | $470 |
| Regeneron Healthcare Solutions, Inc. | 15 | $306 |
| E.r. Squibb & Sons, L.L.C. | 6 | $289 |
| Johnson & Johnson | 6 | $278 |
| Pfizer | 10 | $215 |
| Galderma Laboratories, L.p. | 7 | $148 |
| Lilly USA, LLC | 4 | $119 |
| Sun Pharmaceutical Industries Inc. | 4 | $105 |
| Sanofi | 4 | $94 |
| Arcutis Biotherapeutics, Inc. | 4 | $88 |
| Novartis | 3 | $68 |
| Cipher Pharmaceuticals US LLC | 1 | $50 |
| Organon | 1 | $23 |
| Boehringer Ingelheim | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,204 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 11 | $1,946 |
| Ammonium Lactate | 28 | $638 |
| Ketoconazole | 22 | $437 |
| Triamcinolone Acetonide | 15 | $164 |
| Mupirocin | 11 | $91 |
Paid to pharmacies, not to this prescriber.
Other family in Bronx
- Vladimir ByhovskyBronx$70K
- May YuBronx$24K
- Daphenie FauvelBronx$21K
- Schevaughn Carr CelestineBronx$20K
- Nighat SaeedBronx$19K
- Keisha BallentineBronx$18K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.